Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Niacinamide enhances cathelicidin mediated SARS-CoV-2 membrane disruption.
Bhatt T, Dam B, Khedkar SU, Lall S, Pandey S, Kataria S, Ajnabi J, Gulzar SE, Dias PM, Waskar M, Raut J, Sundaramurthy V, Vemula PK, Ghatlia N, Majumdar A, Jamora C. Bhatt T, et al. Among authors: lall s. Front Immunol. 2023 Nov 8;14:1255478. doi: 10.3389/fimmu.2023.1255478. eCollection 2023. Front Immunol. 2023. PMID: 38022563 Free PMC article.
ASPORIN: A root of the matter in tumors and their host environment.
Lall SP, Alsafwani ZW, Batra SK, Seshacharyulu P. Lall SP, et al. Biochim Biophys Acta Rev Cancer. 2024 Jan;1879(1):189029. doi: 10.1016/j.bbcan.2023.189029. Epub 2023 Nov 24. Biochim Biophys Acta Rev Cancer. 2024. PMID: 38008263 Review.
Evidence-based opioid prescribing guidelines after lung resection: a prospective, multicenter analysis.
Mondoñedo JR, Brescia AA, Clark MJ, Chang ML, Jiang S, He C, Welsh RJ, Popoff AM, Kulkarni MG, Lall SC, Pratt JW, Adams KN, Alnajjar RM, Martin JR, Gandhi DB, Brummett CM, Chang AC, Lagisetty KH. Mondoñedo JR, et al. Among authors: lall sc. J Thorac Dis. 2023 Jun 30;15(6):3285-3294. doi: 10.21037/jtd-22-1621. Epub 2023 Jun 21. J Thorac Dis. 2023. PMID: 37426143 Free PMC article.
Targeting the EGFR signaling pathway in cancer therapy: What's new in 2023?
Halder S, Basu S, Lall SP, Ganti AK, Batra SK, Seshacharyulu P. Halder S, et al. Among authors: lall sp. Expert Opin Ther Targets. 2023 Apr-May;27(4-5):305-324. doi: 10.1080/14728222.2023.2218613. Epub 2023 Jun 2. Expert Opin Ther Targets. 2023. PMID: 37243489 Review.
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial.
Parry MA, Grist E, Mendes L, Dutey-Magni P, Sachdeva A, Brawley C, Murphy L, Proudfoot J, Lall S, Liu Y, Friedrich S, Ismail M, Hoyle A, Ali A, Haran A, Wingate A, Zakka L, Wetterskog D, Amos CL, Atako NB, Wang V, Rush HL, Jones RJ, Leung H, Cross WR, Gillessen S, Parker CC, Chowdhury S; STAMPEDE collaborators; Lotan T, Marafioti T, Urbanucci A, Schaeffer EM, Spratt DE, Waugh D, Powles T, Berney DM, Sydes MR, Parmar MKB, Hamid AA, Feng FY, Sweeney CJ, Davicioni E, Clarke NW, James ND, Brown LC, Attard G. Parry MA, et al. Among authors: lall s. Res Sq [Preprint]. 2023 Feb 8:rs.3.rs-2488586. doi: 10.21203/rs.3.rs-2488586/v1. Res Sq. 2023. PMID: 36798177 Free PMC article. Preprint.
195 results